The largest database of trusted experimental protocols

Corsodyl

Manufactured by GlaxoSmithKline
Sourced in United Kingdom, Belgium, Germany, Italy

Corsodyl is a mouthwash product developed by GlaxoSmithKline. It contains the active ingredient chlorhexidine gluconate, which is an antiseptic used to help reduce the build-up of plaque and the risk of gum disease.

Automatically generated - may contain errors

18 protocols using corsodyl

1

Antibacterial Toothpaste Effectiveness on Oral Models

Check if the same lab product or an alternative is used in the 5 most similar protocols
The test groups were as follows:

A high-molecular-weight hyaluronic-acid-containing toothpaste (non-commercial) diluted in PBS at a 20% (v/v) concentration;

A fluoride-containing toothpaste (Aquafresh, GSK, Weybridge, UK) diluted in PBS at a 20% (v/v) concentration;

A 67% sodium-bicarbonate-containing toothpaste (Corsodyl, GSK, Weybridge, UK) diluted in PBS at a 20% (v/v) concentration;

The antibiotics penicillin and streptomycin (100 IU:100 mg/mL) (Sigma, Dorset, UK);

A 0.2% w/v chlorhexidine digluconate mouthwash (Corsodyl, GSK, Weybridge, UK);

Mechanical rinsing with phosphate-buffered saline (PBS) using a pipette;

No bacterial removal;

Oral mucosal models without bacteria.

+ Open protocol
+ Expand
2

Perioperative Dental Hygiene and Pain Management

Check if the same lab product or an alternative is used in the 5 most similar protocols
Professional oral hygiene was applied 7–10 days prior to surgery. One hour before the operation, all patients received antibiotic prophylaxis with 2-g amoxicillin + clavulanic acid (Augmentin, GlaxoSmithKline, Italy) to prevent postsurgical infection.
Fifteen minutes before surgery, one tablet containing either 500-mg paracetamol + 30-mg codeine (Coefferalgan, Farma 1000, Italy) or starch (placebo) was administered orally; the two types of tablets had an identical appearance. Immediately before applying local anaesthesia, all participants were instructed to execute three mouth rinses with an antiseptic at 0.20 mg/ml (0.2% chlorhexidine, Corsodyl, GlaxoSmithKline, Italy).
Postsurgical instructions were given to each patient concerning food consumption as well as hygiene at the surgical site (0.2% chlorexidine spray, Corsodyl, GlaxoSmithKline, Italy). During this period, both groups of patients (analgesic and placebo) were allowed to take the same paracetamol-codeine tablets given preoperatively at 6-hour intervals depending on their pain symptoms (up to a maximum of 4-g paracetamol and 240-mg codeine per 24 hours). Any adverse events (nausea, vomiting, headaches, or dizziness) occurring between the start of the trial and 1 week later at the time of suture removal were recorded.
+ Open protocol
+ Expand
3

Postoperative Care for Dental Implants

Check if the same lab product or an alternative is used in the 5 most similar protocols
No postoperative antibiotics were prescribed, but we instructed participants to take 3 g of paracetamol daily for 10 days and to rinse their mouths with a solution of chlorhexidine digluconate (0.2%; Corsodyl, GlaxoSmithKline Consumer Healthcare, Buhl, Germany) for 1 min, twice daily for 10 days. We removed the sutures 10 days after surgery. Patients were asked to avoid mechanical brushing on the treated region for one week. A control healing visit occurred one week postsurgery, during which sutures were removed and participants were recommended to conduct a soft mechanical cleaning, beginning with the second week after the intervention, using a very soft surgical dental brush with 0.15 mm bristles (Meridol®, GABA International AG, Therwil, Switzerland). Participants could progressively resume their usual oral hygiene measures from the third week after surgery. Three months and six months after surgery they returned for professional supragingival cleaning around the implant and teeth (performed by ST) and a reminder of oral hygiene technique.
+ Open protocol
+ Expand
4

Biofilm Killing with CHX and DC

Check if the same lab product or an alternative is used in the 5 most similar protocols
After each experiment, 10 biofilms were formed and ready to be treated individually according to one of the following procedures: CHX 0.2% (five discs) or CHX 0.2% + 5 mA DC (five discs).
Indeed, two series of five discs/biofilms were removed aseptically from the splints with Friedman Gouge forceps after each experiment and prepared for the ex vivo biofilm killing assay. The first series (five samples) was only submitted, through immersion of the discs, to the action of CHX previously poured into a sterile Petri dish (Corsodyl®, GlaxoSmithKline, UK). The second one (five samples) was additionally and concomitantly treated with a 5 mA DC allowed by the activation of a customized electrified tray (Inéo™, SATELEC, Acteon Group, Mérignac, France) (Fig. 2). This experimental device only allows for 5 mA DCs so that it was not possible to test several other currents. Each modality of treatment was applied during 5 min, and its bactericidal efficacy evaluated after 30 sec, 1, 2, and 5 min. To do so, at each time point (T0, 30 sec, 1, 2, 5 min), one disc was removed from the antiseptic solution, washed during 3 sec with sterile phosphate‐buffered saline (PBS), and transferred in a microtube containing 1 mL of PBS.
+ Open protocol
+ Expand
5

Antibiotic and Chlorhexidine Rinse Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
All patients took two tablets of Amoxicillin 875 mg + Clavulanic acid 125 mg (Augmentin, Glaxo Smith Kline, Brentford, UK) 1 h before the procedure.
Before starting with the procedure, patients rinsed their mouth with chlorhexidine at 0.2% [29 ,30 (link)] (Corsodyl, GlaxoSmithKline, Rixensart, Belgium) for one minute.
+ Open protocol
+ Expand
6

Post-operative Antibiotic and Oral Care

Check if the same lab product or an alternative is used in the 5 most similar protocols
For the entire duration of the post-operative period, all patients were prescribed:

1 g of Amoxicillin 875 mg + Clavulanic acid 125 mg (Augmentin, Glaxo Smith Kline, Brentford, UK) twice a day for a period of five days after the procedure;

0.20% chlorhexidine mouthwash (Corsodyl, GlaxoSmithKline, Rixensart, Belgium) rinse two times a day for around one minute for the next 15 days;

Soft diet for the two months after the surgical;

The light smokers were remembered to limit and possibly to refrain from smoking.

+ Open protocol
+ Expand
7

Oral Hygiene and Antibiotic Prophylaxis in Dental Surgery

Check if the same lab product or an alternative is used in the 5 most similar protocols
All participants received education on the significance of maintaining proper oral hygiene and were provided with personalized guidance. The local prophylactic protocol was adhered to, involving the administration of either 2,000 mg of amoxicillin/clavulanic acid orally or 600 mg of clindamycin orally, 60 min prior to surgery. Following the application of local anesthetics, participants were instructed to perform a 30-s rinse with a 0.2% chlorhexidine solution (Corsodyl®, GlaxoSmithKline, Brentford, United Kingdom). Subsequently, the surgical procedures were carried out by the same experienced surgeon (M.Á.A.).
+ Open protocol
+ Expand
8

Comprehensive Oral Hygiene Regimen for Implant Surgery

Check if the same lab product or an alternative is used in the 5 most similar protocols
Before the surgical treatment, all patients underwent an oral hygiene protocol that consisted of polishing when needed, and supra- and subgingival debridement. One hour prior to surgery, patients received prophylactic antibiotic therapy with 2 g of Amoxicillin (Augmentin, GlaxoSmithKline, London, UK). Immediately before the procedure, they were instructed to rinse with a 0.2% chlorhexidine digluconate solution (Corsodyl, GlaxoSmithKline Consumer Healthcare, Genval, Belgium) for 2 min. All surgical procedures were performed by the same experienced surgeon (L.V.S.). Local anesthesia with 2% mepivacaine 1:100,000 adrenalin (Carbocaine, AstraZeneca, Milan, Italy) was used.
The surgical strategy first provided the placement of implants (TPA, AZ implant, San Lazzaro di Savena, Bologna, Italy) at healed sites and then the extractions of the teeth where immediate implants were planned and at the end the others remaining extractions.
After implant insertion and teeth extraction, the multi-unit abutments were screwed (Figure 6), and an impression was taken to prepare a provisional screwed retained prosthesis.
The healing screws were screwed after 6 h, the provisional prosthesis was screwed, and an occlusal check was performed (Figure 7).
+ Open protocol
+ Expand
9

Post-surgical Antibiotic and Analgesic Regimen

Check if the same lab product or an alternative is used in the 5 most similar protocols
All patients were prescribed amoxicillin (Augmentin, GlaxoSmithKline, London, UK) 1 g twice daily for seven days. After surgery, analgesia was achieved with 200 mg of ketoprofen (Ibifen, Aprilia, Latina, Italy) for a maximum of three times days according to the needs of individual patients. Each patient was instructed to rinse with 0.12% chlorhexidine digluconate (Corsodyl, GlaxoSmithKline Consumer Healthcare S.p.A., Baranzate, Milan, Italy) three times daily for two weeks, to follow a soft diet for one week, and to gently clean with a soft toothbrush while avoiding flossing in the surgical area for the first month post-operatively.
+ Open protocol
+ Expand
10

Enamel Matrix Derivative in Periodontal Regeneration

Check if the same lab product or an alternative is used in the 5 most similar protocols
Clinical measurements were obtained at baseline. Full-thickness mucoperiosteal flaps were elevated on the buccal, lingual and interproximal aspects of the involved teeth. Granulation tissue adherent to the alveolar bone was removed. Remaining subgingival calculus was removed with curettes. Following open flap debridement, teeth were randomly assigned to receive either the test or the control treatment by the tossing of a coin. In the test sites, EMD in propylene glycol alginate (Emdogain; Straumann, Basel, Switzerland) was directly applied to the exposed alveolar bone as well as onto the root surfaces. Flaps were repositioned and tension-free primary closure of the wound was achieved by means of single non-resorbable sutures (Propylen 5.0; Medipac, Kilkis, Greece). Control sites received the same surgical procedure but without the application of Emdogain. Sutures were removed after 14 days. Patients were advised to rinse twice daily with a 0.2% solution of chlorhexidine digluconate (Corsodyl; GlaxoSmithKline, Münchenbuchsee, Germany) for 2 weeks. No antibiotics were given48 (link)49 (link), and mechanical oral hygiene was not allowed in the surgical areas during this period. Analgesics were taken by the patients on an as needed basis.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!